Overall | 1996–2000 | 2001–2005 | 2006–2009 | 2010–2013 | 2014–2017 | P-Value | |
---|---|---|---|---|---|---|---|
Total – no. (%) | 4285 (100.0) | 790 (100.0) | 1031 (100.0) | 854 (100.0) | 751 (100.0) | 859 (100.0) | |
Sex – no. (%) | |||||||
Male | 2729 (63.7) | 505 (63.9) | 628 (60.9) | 526 (61.6) | 504 (67.1) | 566 (65.9) | < 0.0001 |
Age, Yr | |||||||
Age, [Q1-Q3] | 67 [57.0–76.0] | 65 [57.0–73.0] | 67 [57.0–75.0] | 67 [56.0–77.0] | 69 [58.0–77.0] | 69 [55.5–76.0] | < 0.0001 |
Age group – no. (%) | |||||||
< 50 | 575 (13.4) | 83 (10.5) | 133 (12.9) | 125 (14.6) | 101 (13.4) | 133 (15.5) | |
50–59 | 724 (16.9) | 163 (20.6) | 176 (17.1) | 140 (16.4) | 101 (13.4) | 144 (16.8) | |
60–69 | 1094 (25.5) | 246 (31.1) | 289 (28.0) | 210 (24.6) | 176 (23.4) | 173 (20.1) | |
70–79 | 1289 (30.1) | 255 (32.3) | 307 (29.8) | 231 (27.0) | 233 (31.0) | 263 (30.6) | |
≥ 80 | 603 (14.1) | 43 (5.4) | 126 (12.2) | 148 (17.3) | 140 (18.6) | 146 (17.0) | < 0.0001 |
Comorbidities – no. (%) | |||||||
Cancer | 291 (6.8) | 50 (6.3) | 60 (5.8) | 54 (6.3) | 50 (6.7) | 77 (9.0) | < 0.0001 |
Diabetes | 1249 (29.1) | 221 (28.0) | 283 (27.4) | 240 (28.1) | 233 (38.7) | 272 (31.7) | 0.398 |
PADa | 219 (5.1) | 44 (5.6) | 69 (6.7) | 53 (6.2) | 25 (3.3) | 28 (3.3) | 0.0001 |
HTb | 2059 (48.1) | 370 (46.8) | 537 (52.1) | 386 (45.2) | 355 (47.3) | 411 (47.8) | < 0.0001 |
AFc | 287 (6.7) | 24 (3.0) | 57 (5.5) | 57 (6.7) | 59 (7.9) | 90 (10.5) | < 0.0001 |
IHDd | 724 (16.9) | 121 (15.3) | 193 (18.7) | 142 (16.6) | 141 (18.8) | 127 (14.8) | 0.267 |
CKDe | 4245 (99.1) | 769 (96.6) | 1023 (99.2) | 847 (99.2) | 751 (100) | 855 (94.1) | < 0.0001 |
ICDf | 44 (1.0) | ≤ 3 (< 0.3) | ≤ 3 (< 0.3) | 9 (1.1) | 10 (1.3) | 18 (2.1) | 0.062 |
HFg | 455 (10.6) | 83 (10.5) | 105 (10.2) | 85 (10.0) | 79 (10.5) | 103 (12.0) | < 0.0001 |
COLDh | 199 (4.6) | 27 (3.4) | 47 (4.6) | 34 (4.0) | 40 (5.3) | 51 (5.9) | 0.0005 |
Prosthetic heart valve | 14 (0.3) | ≤ 3 (< 0.3) | ≤ 3 (< 0.3) | ≤ 3 (< 0.3) | 4 (0.5) | 6 (0.7) | 0.195 |